发明名称 |
Combined Acetylcholinesterase Inhibitor and Quaternary Ammonium Antimuscarinic Therapy to Alter Progression of Cognitive Diseases |
摘要 |
A method administers quaternary ammonium anti-cholinergic muscarinic receptor antagonists in combination with acetyl-cholinesterase inhibitors to treat either cognitive impairment or acute delirium. This therapy results in a modification of a cognitive disorder or disease, namely a slow down in the disease progression. In one preferred embodiment, the disease is dementia with Lewy Bodies. New formulations for quaternary ammonium anti-cholinergic muscarinic receptor antagonists are also disclosed. |
申请公布号 |
US2016346248(A1) |
申请公布日期 |
2016.12.01 |
申请号 |
US201615233188 |
申请日期 |
2016.08.10 |
申请人 |
Qaam Pharmaceuticals, LLC |
发明人 |
Rich Steven A. |
分类号 |
A61K31/40;A61K31/439;A61K9/70;A61K31/445;A61K31/27;A61K9/00 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
Canandaigua NY US |